US Broker Ratings

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: Exploring 38.27% Potential Upside Amid Robust Revenue Growth

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a Cambridge, Massachusetts-based biopharmaceutical company, is making waves in the biotechnology sector with its innovative focus on cellular metabolism. With a current market capitalization of..

Kiniksa Pharmaceuticals (KNSA) Stock Analysis: Uncovering a 37% Upside Potential in the Healthcare Sector

Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) has been making waves in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market capitalization of $2.44 billion, this..

SS Innovations International (SSII): A Promising Player in India’s Medical Robotics Sector with 40.8% Revenue Growth

SS Innovations International Inc. (SSII), a key player in the burgeoning healthcare sector, is making waves with its cutting-edge innovations in surgical robotics. Headquartered in Gurugram, India, the company has..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: A 205% Potential Upside in the Biotech Arena

Ultragenyx Pharmaceutical Inc. (RARE), a prominent player in the biotechnology sector, is capturing investor attention with a staggering 205% potential upside, according to analyst ratings. This California-based company, with a..

Acadia Healthcare (ACHC) Stock Analysis: Exploring a Potential 95.87% Upside

For individual investors keeping a keen eye on the healthcare sector, Acadia Healthcare Company, Inc. (NASDAQ: ACHC) presents a compelling investment opportunity. Operating within the medical care facilities industry, Acadia..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Growth Potential with 122.91% Upside

Denali Therapeutics Inc. (NASDAQ: DNLI), a pioneering player in the biopharmaceutical sector, is capturing the attention of investors with a substantial potential upside of 122.91%. This U.S.-based biotechnology firm, with..

Surgery Partners, Inc. (SGRY) Stock Analysis: Navigating a 39.92% Potential Upside in the Healthcare Sector

Surgery Partners, Inc. (NASDAQ: SGRY) has garnered significant attention within the healthcare sector, particularly among investors seeking opportunities in medical care facilities. With a market capitalization of $2.85 billion, this..

Neogen Corporation (NEOG) Stock Analysis: Key Insights on Valuation and Growth Potential

Neogen Corporation (NASDAQ: NEOG), a prominent player in the healthcare sector specializing in diagnostics and research, presents a complex picture for investors to consider. Despite its current challenges, the company..

Apogee Therapeutics, Inc. (APGE) Investor Outlook: Potential 159.80% Upside Awaits

Apogee Therapeutics, Inc. (APGE), a promising player in the biotechnology sector, has been capturing the attention of investors with its focus on developing novel biologics for inflammatory and immunology indications...

AtriCure, Inc. (ATRC) Stock Analysis: Strong Buy Ratings Propel a 37.55% Potential Upside

AtriCure, Inc. (NASDAQ: ATRC), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, has been capturing the attention of investors with its robust growth..

BGM Group Ltd. (BGM): Investor Outlook on a Challenging Year for the Chinese Healthcare Contender

BGM Group Ltd. (BGM), a China-based company engaged in the manufacture and distribution of active pharmaceutical ingredients and traditional Chinese medicine derivatives, faces significant challenges amidst a turbulent sector landscape...

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Unveiling a 24% Upside Potential in the Medical Device Sector

Alphatec Holdings, Inc. (NASDAQ: ATEC) has captured investor attention with its impressive market presence and innovative contributions to the healthcare sector, particularly in the niche of medical devices. As a..

Biohaven Ltd. (BHVN) Stock Analysis: Unpacking a Potential 268% Upside in Biotech Innovation

Biohaven Ltd. (NASDAQ: BHVN), a notable player in the biotechnology sector, is capturing the attention of investors with its promising therapeutic pipeline and a staggering potential upside of 268.52%. With..

GeneDx Holdings Corp. (WGS) Stock Analysis: Navigating a 45.60% Revenue Growth in the Genomics Sector

GeneDx Holdings Corp. (NASDAQ: WGS), a prominent player in the genomics sector, has garnered significant attention due to its innovative approach to genetic testing services. Specializing in pediatric and rare..

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Biotechnology Innovator with a 14.94% Potential Upside

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) is making waves in the biotechnology sector, not only for its innovative approach to drug discovery but also for its intriguing financial potential. With a..

PROCEPT BioRobotics Corporation (PRCT) Stock Analysis: A 52.78% Potential Upside Amid Robust Revenue Growth

Investors looking to explore innovative companies in the healthcare sector should consider PROCEPT BioRobotics Corporation (NASDAQ: PRCT), a leader in the medical devices industry. The company is making waves with..

GRAIL, Inc. (GRAL) Stock Analysis: Potential 21.88% Upside Beckons Investors

GRAIL, Inc. (NASDAQ: GRAL), a pioneering company in the healthcare sector, is making waves with its innovative approach to cancer detection. Headquartered in Menlo Park, California, GRAIL is at the..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Exploring a 187% Potential Upside in Biotech Innovation

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) is capturing investor attention with a compelling growth narrative in the biotech sector. Specializing in the discovery and development of therapies for muscle disorders, Edgewise..

Perrigo Company plc (PRGO) Investor Outlook: Exploring a 34% Potential Upside in the Healthcare Sector

Perrigo Company plc (NYSE: PRGO) stands as a prominent player in the healthcare sector, primarily focusing on over-the-counter health and wellness solutions. With a market capitalization of $3.71 billion, this..

Liquidia Corporation (LQDA) Stock Analysis: A 55% Upside Potential Amid Biotech Innovation

Liquidia Corporation (NASDAQ: LQDA) is a compelling player in the biotechnology sector, offering promising growth prospects driven by its innovative approach to addressing unmet medical needs. As a biopharmaceutical company..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds